Get the Stockscreener App
10.70
4.46%
-0.50
After Hours:
10.70
Transcode Therapeutics Inc stock is traded at $10.70, with a volume of 6,968.
It is down -4.46% in the last 24 hours and down -7.00% over the past month.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
See More
Previous Close:
$11.20
Open:
$11.29
24h Volume:
6,968
Relative Volume:
0.22
Market Cap:
$8.92M
Revenue:
-
Net Income/Loss:
$-14.93M
P/E Ratio:
-0.0402
EPS:
-266.137
Net Cash Flow:
$-15.87M
1W Performance:
-2.46%
1M Performance:
-7.00%
6M Performance:
-62.54%
1Y Performance:
-95.42%
1-Day Range:
$10.66
$11.29
1-Week Range:
$10.42
$11.45
52-Week Range:
$6.1478
$739.20
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Name
Transcode Therapeutics Inc
Sector
Industry
Phone
857-301-6857
Address
6 LIBERTY SQUARE, BOSTON
Compare RNAZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
10.70 | 8.92M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Transcode Therapeutics Inc Stock (RNAZ) Latest News
Is TransCode Therapeutics Inc. still worth holding after the dipEarnings Trend Report & Weekly Return Optimization Alerts - Newser
Can TransCode Therapeutics Inc. recover in the next quarterPortfolio Performance Report & Daily Volume Surge Trade Alerts - Newser
Visual analytics tools that track TransCode Therapeutics Inc. performanceWeekly Stock Report & Short-Term High Return Ideas - Newser
What institutional flow reveals about TransCode Therapeutics Inc.July 2025 Breakouts & AI Driven Stock Price Forecasts - Newser
TransCode Therapeutics Inc. stock trendline breakdown2025 Buyback Activity & Daily Profit Focused Screening - Newser
Is TransCode Therapeutics Inc. stock entering bullish territoryRisk Management & Consistent Profit Alerts - Newser
Using AI based signals to follow TransCode Therapeutics Inc.Portfolio Value Report & Consistent Income Trade Recommendations - Newser
Technical analysis overview for TransCode Therapeutics Inc. stockMarket Movement Recap & Expert Approved Momentum Ideas - Newser
will transcode therapeutics inc. continue its uptrendJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - Newser
Can volume confirm reversal in TransCode Therapeutics Inc.2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Will TransCode Therapeutics Inc. continue its uptrend2025 Investor Takeaways & AI Powered Market Entry Ideas - Newser
TransCode Therapeutics Inc. stock outlook for YEARJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - Newser
Is TransCode Therapeutics Inc. forming a bottoming baseQuarterly Earnings Summary & Intraday High Probability Setup Alerts - Newser
Chart based analysis of TransCode Therapeutics Inc. trendsJuly 2025 Update & Accurate Technical Buy Alerts - Newser
What to expect from TransCode Therapeutics Inc. in the next 30 daysJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - Newser
Is TransCode Therapeutics Inc. reversing from oversold territoryWeekly Gains Report & Reliable Intraday Trade Plans - Newser
Sentiment analysis tools applied to TransCode Therapeutics Inc.Gold Moves & Daily Entry Point Alerts - Newser
Can momentum traders help lift TransCode Therapeutics Inc.Trade Ideas & Verified Technical Trade Signals - Newser
Measuring TransCode Therapeutics Inc.’s beta against major indicesPortfolio Update Report & Growth Oriented Trading Recommendations - Newser
Can TransCode Therapeutics Inc. hit a new high this monthQuarterly Risk Review & Safe Capital Growth Trade Ideas - Newser
Will TransCode Therapeutics Inc. stock recover after earningsJuly 2025 Technicals & Fast Entry and Exit Trade Plans - Lancaster City Council
What earnings revisions data tells us about TransCode Therapeutics Inc.Portfolio Growth Summary & Long-Term Growth Stock Strategies - Newser
Full technical analysis of TransCode Therapeutics Inc. stock2025 Institutional Moves & Long-Term Safe Investment Ideas - Newser
Will TransCode Therapeutics Inc. Recover After Recent DeclineWeekly Stock Recap & Fast Exit and Entry Strategy Plans - beatles.ru
Will TransCode Therapeutics Inc. stock go up in YEARMarket Sentiment Review & High Return Trade Opportunity Guides - beatles.ru
Transcode Therapeutics Inc Stock (RNAZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):